...
首页> 外文期刊>Pharmaceutical development and technology >Design and evaluation of ocular drug delivery system for controlled delivery of gatifloxacin sesquehydrate: In vitro and in vivo evaluation.
【24h】

Design and evaluation of ocular drug delivery system for controlled delivery of gatifloxacin sesquehydrate: In vitro and in vivo evaluation.

机译:加替沙星倍半水合物可控递送的眼用药物递送系统的设计和评估:体外和体内评估。

获取原文
获取原文并翻译 | 示例
           

摘要

The objective of this investigation was to formulate ocular inserts of gatifloxacin sesquehydrate to achieve controlled drug release. Drug reservoir was prepared using hydrophilic polymers, namely polyvinyl alcohol and polyvinyl pyrrolidone. The rate controlling membrane was prepared using hydrophobic ethyl cellulose by solvent casting method. Ocular inserts were evaluated for uniformity of weight, thickness, drug content, surface pH, percentage moisture absorption, percentage moisture loss, drug excipients compatibility, in vitro release, sterility test, eye irritation, in vivo release, microbiological and stability studies. Ocular inserts complied with all the physico-chemical parameters. Drug excipients compatibility studies demonstrated no interaction between drug and polymer. The in vitro release profile of drug from ocular inserts showed controlled and prolonged release. The release data followed zero order and non-Fickian transport. Ocular inserts passed the test for sterility. Correlation between in vitro and in vivo drug release was found to be strong revealing the efficacy of the formulation. The drug was found to be effective against Staphylococcus aureus and Escherichia coli. The result of accelerated stability study revealed no significant change in drug content of promising formulation.
机译:这项研究的目的是配制加替沙星倍半水合物的眼用插入物,以实现受控的药物释放。使用亲水性聚合物即聚乙烯醇和聚乙烯吡咯烷酮制备药物贮库。使用疏水性乙基纤维素通过溶剂流延法制备速率控制膜。评估了眼插入物的重量,厚度,药物含量,表面pH值,吸湿率,水分损失率,药物赋形剂相容性,体外释放,无菌试验,眼睛刺激性,体内释放,微生物和稳定性研究的均匀性。眼用插入物符合所有理化参数。药物赋形剂的相容性研究表明药物与聚合物之间没有相互作用。药物从眼部插入物的体外释放曲线显示出受控和延长的释放。释放数据遵循零阶和非菲克式传输。眼用插入物通过了无菌测试。发现体外和体内药物释放之间的相关性很强,揭示了该制剂的功效。发现该药物对金黄色葡萄球菌和大肠杆菌有效。加速稳定性研究的结果表明,有前途的制剂的药物含量没有明显变化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号